Researchers at Seoul National University Hospital have found that non-vitamin K oral anticoagulant (NOAC) is effective i...
The International Diabetes Federation (IDF) Congress is bringing together the global diabetes community to tackle a broa...
KT Corp. said its Global Epidemic Prevention Platform (GEPP) started service in Ghana on 14th, the first such ...
Headquartered in Switzerland, The Straumann Group has entered into a partnership with Yuhan Corporation, Korea’s l...
Samsung BioLogics (SBL) has successfully performed N-1 (3,000L) perfusion with Alternating Tangential Flow (ATF) device ...
Gencurix, Inc., a Korea based company dedicated in development and market of innovative molecular diagnostics, has annou...
South Korea’s plans to invest more than US$1.7bn in its biotechnology and biopharmaceutical sectors over the next ...
SillaJen, Inc., a South Korea based clinical-stage, biotherapeutics company focused on the development of oncolytic immu...
Already home to more than 40 pharmaceutical multinationals, Korea is on course to become a global biotech and pharmaceut...
South Korea headquartered Samsung BioLogics (SBL) and Belgium based biopharmaceutical company UCB have agreed to an addi...
Mezzion Pharma Co. Ltd., a biotech company based in Korea, haas announced that top line data from the Phase 3 Fonta...
LISCure Biosciences, a South Korea based biotech company that researches and develops bacteria-mediated immunotherapy, h...
Samsung Bioepis becomes the first company to receive FDA approvals for biosimilars referencing all three first-generatio...
Shinsung TK, a Korean company specializing in security system based on IoT (Internet of Things) technology, has become v...
South Korea based Orum Therapeutics has announced an oversubscribed $30 million Series B financing. New investors, ...
The company also supported a recent HeForShe movement sponsored by the city of Jechoen. HeforShe is an UN-led gender equ...
Janssen Korea Ltd. and Johnson & Johnson Innovation LLC, on 17 July 2019, announced the launch of the Seoul Innovati...
Contera Pharma, a Danish subsidiary of South Korea based Bukwang Pharmaceutical, has attracted 3 billion won in Series A...
